Ken Griffin's position in Bolt Biotherapeutics is currently worth $3.25 Million. That's 0.00% of their equity portfolio (1884th largest holding). The investor owns 7.60% of the outstanding Bolt Biotherapeutics stock. The first Bolt Biotherapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares five more times and sold shares on six occasions. The investor's estimated purchase price is $74 Million, resulting in a loss of 96%.